ABSTRACT Bean leaf tumors induced by Agrobacterium tumefaciens strain 181 show enhanced growth in response to octopine or lysopine only if one of these compounds is present during the period of tumor induction. Either compound applied during this period results in tumors which subsequently respond to both. The combined action of the bacterium plus octopine or lysopine at induction is proposed to induce transcription of plant genes coding for enzymes involved in the degradation and/or biosynthesis of octopine and lysopine.
The unusual amino acids, N'-(D-1-carboxyethyl)-L-arginine (octopine) and N2-(D-1-carboxyethyl)-L-lysine (lysopine), are both produced by plant tumors induced by strains of Agrobacterium tumefaciens which can utilize octopine in vitro (15) . Most virulent agrobacteria utilize either octopine or nopaline (N2_(?_1,3-dicarboxypropyl)-L-arginine) (10) and strains which utilize nopaline induce tumors which produce nopaline but not octopine or lysopine. These differences in tumor biosynthetic capacity are thus correlated with the tumor-inducing strain of bacteria and constitute heritable changes in plant cell metabolism, as production of these compounds persists in the tumor tissues when grown in culture free of the bacterium (15) .
Tumors induced on bean leaves by octopine-utilizing strains of A. tumefaciens show increased growth in response to exogenous octopine or lysopine (9) . These octopine-type tumors show little growth promotion on application of nopaline, whereas tumors induced by nopaline-utilizing strains are responsive to nopaline but in most cases do not respond to octopine or lysopine (11; Lippincott and Lippincott, unpublished data). Tumors induced by octopine-utilizing strains of Agrobacterium show specificity in producing and responding to octopine, and tumors induced by nopaline-utilizing strains both produce and respond to nopaline. A similar correlation between production and growth responsiveness is also found for two other tumor-produced substances which are potentially in growth-limiting supply, -y-aminobutyric acid (14) , and an unresolved histidine derivative whose activity is mimicked by B3-alanyl-L-histidine (carnosine) (1 1, 14) . neither octopine plus lysopine nor nopaline (Morel, personal communication). This is a nopaline-type strain, however, since it utilizes nopaline in culture but cannot utilize octopine (10) . Table I shows that bean leaf tumors induced by strain 181 show no growth promotion in response to octopine or lysopine when added at day 3 following inoculation of the bacteria. These tumors are responsive to carnosine added in this fashion, however, and the carnosine-like tumor growth factor (TGF-I) can be extracted from leaves inoculated with strain 181 (13; Lippincott and Lippincott, unpublished data).
Data in Table II show that neither carnosine, octopine, nor lysopine promotes growth of strain 181-induced tumors when added shortly after inoculation of the bacteria. However, if the octopine or lysopine treatment at the time of inoculation is followed by a second application made at day 3, tumor growth is promoted. Two applications of octopine within the first 10 hr after inoculation did not promote growth, and application of carnosine at 15 min and 3 days was no more effective than a single application of carnosine at the later time, indicating the growth promotions obtained by lysopine and octopine are not simple concentration effects.
Tumor induction on bean leaves occurs only during the first 20 hr after inoculation (7) and thereafter further tumor enlargement depends on growth. The addition of octopine or lysopine to the bean leaves during the period of tumor induction thus results in the formation of 181-induced tumors whose growth becomes responsive to these compounds when added Theoretically, the action of octopine or lysopine in inducing responsiveness in 181-induced tumors might be on the bacterium, the host, or both. Since strain 181 utilizes nopaline but not octopine, however, and nopaline-type strains are not known to induce octopine-type tumors, it appears unlikely that this action is on the bacterium. There is evidence that both lysopine (1, 16) and octopine (4, 18) are produced by normal plants but at a much lower level than by tumors. We propose that the ability of lysopine or octopine to induce responsiveness to these same compounds in strain 181 tumors results from the activation of host genetic information controlling lysopine and octopine biosynthesis. A system analogous to product induction of an enzyme is envisaged, similar to the action of kynurenine or urocanate in inducing the enzymes responsible for their biosynthesis (2, 12). Either octopine or lysopine may specifically derepress plant genes which control synthesis of both lysopine or octopine dehydrogenases. Since octopine and lysopine production are normally correlated in bacterial tumors induced in vivo and responsiveness of 181-induced tumors to both octopine and lysopine is promoted by either compound, the structural genes for octopine and lysopine dehydrogenases may be controlled by a single regulatory gene. LITERATURE 
